Finished

Evaluation of the Effectiveness and Safety of Keeogo™ Dermoskeleton in Subjects With Mobility Impairments Due to Stroke

NCT03986320 · B-Temia, Inc. · Updated 30 Sept 2026

What is being tested: Keeogo™ Dermoskeleton
For: Stroke, Ischemic; Stroke Hemorrhagic; Stroke; Hemiparesis; Cerebral Vascular Accident
Kind of study: Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join: Ages 18 years and older. About 60 people. The full rules are on the registry page.
Where: United States, Canada (4 sites)
When: Starts or started 22 July 2019, ends 10 Sept 2020. Registered 14 June 2019.
Results: None posted yet.

In the researchers' words

A multi-site, interventional, non-comparative, single-arm trial to evaluate the safety of the Keeogo™ Dermoskeleton in subjects with hemiparesis due to ischemic or hemorrhagic stroke.

ClinicalTrials.gov, NCT03986320

Sites

Shirley Ryan Ability Lab (SRA)Chicago, Illinois, United States
Human Performance and Engineering Research (HPER)West Orange, New Jersey, United States
James J Peters VA Medical Center - Center for the Medical Consequences of Spinal Cord InjuryThe Bronx, New York, United States
Assistive Technology Clinic (ATC)Toronto, Ontario, Canada